DUBLIN, July 2, 2018 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced that the U.S. Food and Drug Administration (FDA) has approved ARISTADA INITIO ™ (aripiprazole lauroxil) for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results